Plain-English translation of NCT05658497 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →This is a registry study that tracks how (a medication used to treat multiple sclerosis) affects pregnancies. Researchers want to understand whether this medication is safe to use during pregnancy by collecting detailed information from women with MS who were exposed to it while pregnant, and comparing their outcomes to women taking other MS treatments or no treatment at all.
When you have multiple sclerosis and become pregnant, doctors and patients need reliable information about whether it is safe to keep taking MS medications. This study exists to gather real-world evidence about this medication's safety during pregnancy so that women with MS can make informed decisions about their treatment.
You likely qualify if…
You likely don't qualify if…
As a participant, you would share information about your pregnancy, your MS treatment history, and the health of your baby at birth. You are not taking a new medication or undergoing procedures — instead, you are helping researchers by providing your medical records and pregnancy outcome information. This is a registry study, meaning it collects existing health data rather than conducting a controlled experiment.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Australia
Germany
Ireland